Legend Biotech has managed to remove GenScript Biotech as its majority shareholder, just as the former parent’s Chinese background falls under a U.S. biosecurity microscope. After a financial ...
Regtechtimes on MSN5mon
U.S. Urges FBI to Investigate Chinese Healthcare Espionage at GenScript and Its 3 SubsidiariesThe U.S. House of Representatives Committee on China has formally requested a briefing from the FBI and the intelligence ...
Genscript Biotech (HK:1548) has released an update. Genscript Biotech’s associate, Legend Biotech, is making strides in the treatment of multiple myeloma, providing promising data from the Phase ...
To guarantee 100% sequence correctness, GenScript’s DNA synthesis process employs on-site sequence optimization and oligo design, followed by oligo synthesis and gene assembly. The unique ...
Genscript Biotech (HK:1548) has released an update. Genscript Biotech has announced the deconsolidation of its subsidiary, Legend Biotech, following changes to their deposit agreement. This ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback